Craig W. Moore, Director at NxStage Medical, Inc. (NXTM), bought 10,000 shares at $4.00 ($40K) on 2008-08-12, disclosed to the SEC on 2008-08-13.
Open-market purchase of $40k NXTM by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| NXTM | SELL | 2015-11-20 | $20K | — | Filing → |
| NXTM | SELL | 2015-11-18 | $78K | — | Filing → |
| NXTM | SELL | 2015-09-16 | $16K | — | Filing → |